These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7176217)

  • 1. Immunopharmacological studies of the aqueous extract of Cinnamomum cassia (CCAq). II. Effect of CCAq on experimental glomerulonephritis.
    Nagai H; Shimazawa T; Takizawa T; Koda A; Yagi A; Nishioka I
    Jpn J Pharmacol; 1982 Oct; 32(5):823-31. PubMed ID: 7176217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopharmacological studies of the aqueous extract of Cinnamomum cassia (CCAq). I. Anti-allergic action.
    Nagai H; Shimazawa T; Matsuura N; Koda A
    Jpn J Pharmacol; 1982 Oct; 32(5):813-22. PubMed ID: 6184511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopharmacological studies on experimental glomerulonephritis.
    Nagai H; Koda A; Mori H; Shimazawa T
    Int J Immunopharmacol; 1983; 5(3):235-44. PubMed ID: 6618743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H; Terada E; Okudaira K
    Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The susceptibility of experimental glomerulonephritis in six different strains of mice.
    Nagai H; Yamada H; Nishigaki T; Nakazawa M; Koda A
    J Pharmacobiodyn; 1985 Jul; 8(7):586-9. PubMed ID: 2933507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopharmacological studies of sodium copper chlorphyllin (SCC).
    Nagai H; Nishiyori T; Daikoku M; Koda A
    Jpn J Pharmacol; 1983 Aug; 33(4):819-28. PubMed ID: 6195383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro.
    Verspohl EJ; Bauer K; Neddermann E
    Phytother Res; 2005 Mar; 19(3):203-6. PubMed ID: 15934022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the alternative complement pathway by unidentified substances in human glomerulonephritis.
    Schena FP; Pertosa G; Vox E; Bonomo L
    Nephron; 1981; 27(1):9-14. PubMed ID: 6908651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of protein excretion by dimethyl sulfoxide in rats with passive Heymann nephritis.
    Lotan D; Kaplan BS; Fong JS; Goodyer PR; de Chadarevian JP
    Kidney Int; 1984 May; 25(5):778-88. PubMed ID: 6471664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.
    Maruyama N; Furukawa F; Nakai Y; Sasaki Y; Ohta K; Ozaki S; Hirose S; Shirai T
    J Immunol; 1983 Feb; 130(2):740-6. PubMed ID: 6217253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental glomerulonephritis in mice as a model for immunopharmacological studies.
    Nagai H; Takizawa T; Nishiyori T; Koda A
    Jpn J Pharmacol; 1982 Dec; 32(6):1117-24. PubMed ID: 6891726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of immune complex trapping by follicular dendritic cells with monoclonal antibodies against rat C3.
    Van den Berg TK; Döpp EA; Daha MR; Kraal G; Dijkstra CD
    Eur J Immunol; 1992 Apr; 22(4):957-62. PubMed ID: 1551408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D; Nazneen A; Taguchi T; Razzaque MS
    Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolysis by the complement of tanned erythrocytes coated with cobra venom factor: a sensitive method to detect the alternative complement pathway activity of serum.
    Okada H; Tanaka H
    J Immunol Methods; 1981; 46(1):85-95. PubMed ID: 6793665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
    Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
    Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic serum sickness glomerulonephritis: removal of glomerular antigen and electron-dense deposits is largely dependent on plasma complement.
    Furness PN; Turner DR
    Clin Exp Immunol; 1988 Oct; 74(1):126-30. PubMed ID: 3219798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis.
    Schulze M; Pruchno CJ; Burns M; Baker PJ; Johnson RJ; Couser WG
    Am J Pathol; 1993 Jan; 142(1):179-87. PubMed ID: 7678717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement system promotes transfer of immune complex across glomerular filtration barrier.
    Fujigaki Y; Batsford SR; Bitter-Suermann D; Vogt A
    Lab Invest; 1995 Jan; 72(1):25-33. PubMed ID: 7837787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental studies on membranous nephropathy. (II) Role of complement system in proteinuria of passive Heymann nephritis.
    Nishi T; Nosaka K; Kawasaki H
    Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):301-7. PubMed ID: 6748340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.